With a revenue increase of 7.75% in the first quarter 2026, year on year to cumulative value of $302 million, Evolus Inc 's revenue per employee grew on a trailing twelve months basis to $ 905,237. The productivity of Evolus Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 55 other companies have achieved higher revenue per employee. While Evolus Inc 's total ranking has deteriorated compared to the previous quarter from 343 to 639. Evolus Inc has 334 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EOLS Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	7.75 %	15.64 %	12.7 %	3.6 %	14.03 %
Sales per Employee (TTM) $	905,237	889,542	852,584	829,362	822,144
EOLS's Total Ranking	# 639	# 343	# 245	# 296	# 184
Seq. Revenue Change	-20.15 %	32.61 %	-0.69 %	2.46 %	-14.3 %

EOLS Company Profile >> Back to EOLS Efficiency Comparisons >> Compare EOLS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 38
Healthcare Sector	# 56
Overall Market	# 639

Revenue per Employee Statistics
High	Average	Low
$ 1,169,048	$ 552,388	$ 135,991
(Sep 30 2025)		(Mar 31 2020)

Financial Statements
Evolus Inc 's Revenue MRQ	$ 73 Millions	Visit EOLS's Income Statement
Evolus Inc 's Revenues TTM	$ 302 Millions	Visit EOLS's aggregate revenue growth
What are EOLS's Sales?		Visit EOLS's Sales by Segment

Other Ratios
Evolus Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EOLS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EOLS's Competitors
Revenue per Employee for EOLS's Suppliers
Revenue per Employee for EOLS's Customers

You may also want to know
EOLS's Sales Growth Rates	EOLS's Pe Price to earnings ratio	EOLS's Receivables Turnover Ratio	EOLS's Stock Quote
EOLS's Net Income Growth Rates	EOLS's Ps Price to Sales ratio	EOLS's Sales per Employee	EOLS's Asset Turnover Ratio
EOLS's Net Margin	EOLS's Pb Price to Book ratio	EOLS's Financial Strength Ratios	EOLS's Dividend Payout Ratio

Date modified: 2026-08-29T17:39:10+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Soleno Therapeutics Inc	1,565,978.02	$ 285.008 Million	182
Neurocrine Biosciences Inc	1,551,200.00	$ 3,102.400 Million	2,000
Jazz Pharmaceuticals Plc	1,535,863.32	$ 4,438.645 Million	2,890
Mirum Pharmaceuticals Inc	1,531,206.99	$ 569.609 Million	372
Agenus Inc	1,529,209.88	$ 123.866 Million	81
Progyny Inc	1,510,233.64	$ 1,292.760 Million	856
Apellis Pharmaceuticals Inc	1,495,642.76	$ 1,105.280 Million	739
Bristol myers Squibb Company	1,491,753.85	$ 48,482.000 Million	32,500
Fennec Pharmaceuticals Inc	1,457,114.29	$ 50.999 Million	35
Tarsus Pharmaceuticals Inc	1,446,159.46	$ 535.079 Million	370
Eli Lilly And Company	1,444,990.00	$ 72,249.500 Million	50,000
Esperion Therapeutics Inc	1,422,598.64	$ 418.244 Million	294
Krystal Biotech Inc	1,414,589.83	$ 417.304 Million	295
Acadia Pharmaceuticals Inc	1,372,493.73	$ 1,095.250 Million	798
Liquidia Corporation	1,333,634.26	$ 288.065 Million	216
Biogen Inc	1,324,986.67	$ 9,937.400 Million	7,500
Lantheus Holdings Inc	1,295,200.34	$ 1,545.174 Million	1,193
Indivior Pharmaceuticals Inc	1,292,000.00	$ 1,292.000 Million	1,000
Puma Biotechnology Inc	1,269,150.84	$ 227.178 Million	179
Madrigal Pharmaceuticals Inc	1,237,693.99	$ 1,132.490 Million	915
Theravance Biopharma inc	1,219,722.22	$ 109.775 Million	90
Akebia Therapeutics Inc	1,197,958.76	$ 232.404 Million	194
Supernus Pharmaceuticals inc	1,191,461.66	$ 776.833 Million	652
Arcutis Biotherapeutics Inc	1,174,079.10	$ 415.624 Million	354
Heron Therapeutics Inc	1,173,312.50	$ 150.184 Million	128
Cue Biopharma Inc	1,128,655.17	$ 32.731 Million	29
Journey Medical Corp	1,115,172.41	$ 64.680 Million	58
Abbvie Inc	1,102,087.72	$ 62,819.000 Million	57,000
Travere Therapeutics Inc	1,078,863.18	$ 536.195 Million	497
Corcept Therapeutics Inc	1,053,556.16	$ 769.096 Million	730

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.